Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE +0.12%, DAX30 +0.32%, CAC40 (0.18%)

Aug 23 ,2023

  • Synopsis

    • European indices are set to open mixed amidst Asia equities trading mixed Wednesday. Japan, Hong Kong and Australia tracking moderate gains after a soft open, while mainland China and South Korea lagging. Regional growth stocks broadly underperforming. US futures gaining momentum after benchmarks finished mostly lower overnight around intraday lows.

    • On today's agenda, statement of Iceland Central Bank's MPC; Monetary Bulletin including updated forecasts. Other events, Nordea small and midcap days (through Thu), Hamburger Investorentag and Gamescom begins (through Sun). In the US, there's first televised debate of Republican presidential candidates being held in Milwaukee. Depending on the number of candidates who qualify (deadline 21-Aug), there may be a second debate night on Thur.

    • Economic releases due today include: Eurozone, France, Germany, UK Aug preliminary manufacturing/services PMIs, Eurozone Aug preliminary consumer confidence.

    • On the reporting front, Mowi (MOWI.NO), Lerøy Seafood Group (LSG.NO), Bavarian Nordic A/S (BAVA.DC), Scandi Standard (SCST.SS), MEKO AB (MEKO.SS) and Austevoll Seafood (AUSS.NO) are amongst other companies from Nordics to update investors with their latest numbers. In DACHs, Autoneum Holding (AUTN.SW) reported H1 earnings. Also reporting today Costain (COST.LN), Sydbank (SYDB.DC), and MDxHealth (MDXH.BB).

  • Politics/Macro/World News

    • British Small Businesses See Sales Sink by 20%, New Data Shows - Bloomberg

    • UK-India trade talks enter 'final, trickier' stage - government sources - BBC

    • Venture capital funds prop up young companies as inflation bites - FT

  • Top company news

    • Earnings/updates

      • Nordix

        • MOWI.NO (Mowi) -- reports Q2 underlying EPS €0.35 vs FactSet €0.37 [9 est, €0.34-0.40]

        • ZAP.NO (Zaptec) -- reports Q2 EPS NOK0.18 vs year-ago NOK0.04

        • VOW.NO (Vow ASA) -- reports H1 result for the period NOK6.3M vs year-ago NOK14.5M

        • BGBIO.NO (BerGenBio) -- reports Q2 EPS (NOK0.15) vs year-ago (NOK0.95)

        • LSG.NO (Lerøy Seafood Group) -- reports Q2 EPS (NOK2.11) vs year-ago NOK0.83

        • ODL.NO (Odfjell Drilling) -- reports Q2 net income $11M vs FactSet $10.0M [2 est, $5-14.9M]; announces new quarterly dividend programme

        • BETCO.SS (Better Collective) -- reports Q2 EPS €0.14 vs year-ago €0.12

        • B2H.NO (B2Holding) -- reports Q2 net income NOK182M vs FactSet NOK93.2M

        • AMSC.NO (AMSC ASA) reports Q2 adjusted net income $4.8M vs FactSet $6.6M

        • AUSS.NO (Austevoll Seafood) -- reports Q2 net income (NOK1.14B) vs FactSet NOK414.4M

        • MULTI.NO( Multiconsult) -- reports Q2 EPS NOK1.30 vs FactSet NOK1.31

        • NEXT.NO (Next Biometrics Group) -- reports Q2 revenue NOK7.3M, (38%) vs year-ago NOK11.7M

        • WSTEP.NO (Webstep) -- reports Q2 EPS NOK0.46 vs year-ago NOK0.36

        • MEKO.SS (MEKO AB) -- reports Q2 EPS SEK3.03 vs year-ago SEK1.73

        • SCST.SS (Scandi Standard) -- reports Q2 EPS SEK1.11 vs year-ago SEK0.07

        • BWE.NO (BW Energy) -- reports H1 net income $0.3M vs year-ago $19.2M

        • DVYSR.SS (Devyser Diagnostics) -- reports Q2 EPS (SEK0.90) vs year-ago (SEK0.90)

        • BAVA.DC (Bavarian Nordic A/S) -- reports Q2 net income DKK538.1M vs FactSet DKK463.1M [5 est, DKK55.6-900M]; FY23 guidance maintained

      • France

        • VIRP.FP (Virbac) -- - 2023 half-year results: publication postponed to end of Septembe

      • Benelux

        • ALFEN.NA (Alfen) -- reports Q2 adjusted EBITDA €8.4M vs FactSet €16.5M [4 est, €14.1-21.8M]

        • FLOW.NA (Flow Traders) -- reports July ETP market data

        • BTLS.BB (Biotalys) -- reports H1 net income (€10.7M) vs year-ago (€9.9M)

        • KENDR.NA (Kendrion) -- reports Q2 net income €3.7M vs year-ago €3.7M

        • AGFB.BB (Agfa-Gevaert) -- reports Q2 net income from cont ops (€17M) vs year-ago (€20M)

      • DACHs

        • ZAG.AV (Zumtobel Group) -- announces updated FY23/24 revenue guidance

        • SENS.SW (Sensirion Holding) -- reports H1 net income CHF1.4M vs year-ago CHF35.0M

        • AUTN.SW (Autoneum Holding) -- reports H1 net income attributable CHF51.3M vs FactSet CHF29.5M [3 est, CHF27.9-30.6M]; reaffirms FY guidance

        • ORON.SW (ORIOR) -- reports H1 net income CHF12.9M vs year-ago CHF13.0M

        • TNIE.GR (tonies) reports Q2 revenue €48.0M, +25% vs year-ago €38.5M

    • M&A

      • BAS.GR (BASF SE) -- BASF exploring sale of ECMS unit - Bloomberg (22-Aug, 14:09 CET)

      • CLF (Cleveland-Cliffs) -- sends letter to US Steel regarding Right to Bid - 8-K

    • Healthcare

      • APLS (Apellis Pharmaceuticals) -- provides updates on rare safety events with SYFOVRE (pegcetacoplan injection)

      • SOBI.SS (Swedish Orphan Biovitrum) -- announces terms of ~SEK 6.024B rights issue

      • CELC (Celcuity) -- enters into a clinical trial collaboration and supply agreement with Bayer (BAYN.GR) to provide Nubeqa (darolutamide) for planned Phase 1B/2 clinical trial

      • VIRP.FP (Virbac) -- launches a share buyback program

    • Other

      • RKT.LN (Reckitt) -- CFO Jeff Carr to depart company ahead of new CEO taking over later this year - Bloomberg

      • ORSTED.DC (Ørsted) -- US Dept. of Interior approves Revolution Wind project off Rhode Island coast

      • AM.FP (Dassault Aviation) -- announces receipt of EASA and FAA Certification for the Falcon 6X

      • VPK.NA (Royal Vopak) -- Gate terminal starts construction of 4th LNG tank at the port of Rotterdam

      • TRE.SM (Tecnicas Reunidas) -- QatarEnergy awards Técnicas Reunidas additional EPC off-plot facilities work for North Field South Project (post EU close 22-Aug)

  • Key rating changes

    • Upgrades

      • GURN.SW (Gurit Holding) -- to outperform from underperform at Credit Suisse

      • ROR.LN (Rotork) -- to buy from add at Peel Hunt

      • SYNT.SS (SyntheticMR) -- upgraded to buy from hold at Pareto

      • GLE.FP (Societe Generale) -- upgraded to overweight from equal-weight at Morgan Stanley

    • Downgrades

      • GN.DC (GN Store Nord) -- to hold from buy at Kepler Cheuvreux

      • TLX.GR (Talanx) -- to hold from buy at HSBC

      • BAKKA.NO (Bakkafrost) -- to hold from buy at Carnegie Securities

      • UNI.IM (Unipol Gruppo) -- to hold from buy at Kepler Cheuvreux

      • PFV.GR (Pfeiffer Vacuum Technology) -- to reduce from hold at Kepler Cheuvreux

      • ELK.NO (Elkem) -- downgraded to equal-weight from overweight at Morgan Stanley

  • Data

    • Nikkei +0.40% to 31985.48

    • Hang Seng +0.66% to 17908.98

    • Shanghai Composite (0.64%) to 3100.40

    • S&P futures +13.0 vs prior close of 4399.3

    • €-$ +0.0012 or +0.11% to 1.0860

    • $-¥ (0.27) or (0.19%) to 145.60

    • €-¥ (0.10) or (0.06%) to 158.13

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE